Esquire Financial Holdings (ESQ) insider receives stock and options in merger
Rhea-AI Filing Summary
Esquire Financial Holdings, Inc. reporting person Michael G. O'Rourke, President of the Chicago Bank Division, reported multiple acquisitions on 2026-08-01 tied to the merger with Signature Bancorporation. Signature common stock and stock options converted into Esquire equity at a 2.671-for-1 ratio, resulting in 66726 common shares held directly and 18630 held indirectly via an IRA, plus several Esquire stock option awards with exercise prices from $19.5700 to $111.1400 per share. Most options are fully vested; one grant vests in five equal annual installments commencing on May 26, 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 85,356 shares
Net Buy
14 txns
Insider
O'ROURKE MICHAEL G
Role
President of Chicago Bank Div
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options F2, F3 | 5,953 | -- | -- |
| Grant/Award | Stock Options F2, F3 | 4,807 | -- | -- |
| Grant/Award | Stock Options F2, F3 | 4,137 | -- | -- |
| Grant/Award | Stock Options F2, F3 | 2,671 | -- | -- |
| Grant/Award | Stock Options F2, F3 | 1,976 | -- | -- |
| Grant/Award | Stock Options F2, F3 | 2,003 | -- | -- |
| Grant/Award | Stock Options F2, F3 | 1,816 | -- | -- |
| Grant/Award | Stock Options F2, F3 | 1,842 | -- | -- |
| Grant/Award | Stock Options F2, F3 | 1,856 | -- | -- |
| Grant/Award | Stock Options F2, F3 | 1,861 | -- | -- |
| Grant/Award | Stock Options F2, F4 | 1,861 | -- | -- |
| Grant/Award | Stock Options F2, F3 | 1,861 | -- | -- |
| Grant/Award | Common Stock F1 | 66,726 | -- | -- |
| Grant/Award | Common Stock F1 | 18,630 | -- | -- |
Holdings After Transaction:
Stock Options — 32,644 shares (Direct);
Common Stock — 66,726 shares (Direct);
Common Stock — 18,630 shares (Indirect, By IRA)
Footnotes (4)
- F1. Pursuant to the Agreement and Plan of Merger dated March 11, 2026 between the Issuer, Signature Bancorporation, Inc. ("Signature") and Esquire Merger Sub, Inc., each issued and outstanding share of Signature common stock was converted into the right to receive 2.671 shares of common stock of Issuer. Holders of Signature Common Stock will receive cash in lieu of fractional shares of Issuer common stock in accordance with the terms of the Agreement and Plan of Merger.
- F2. This option converted into a stock option exercisable for a number of shares of Issuer common stock equal to the number of shares of Signature common stock underlying the option multiplied by 2.671, rounded down to the nearest whole share, with an exercise price per share of Issuer common stock equal to the exercise price applicable to the underlying option divided by 2.671, rounded up to the nearest cent.
- F3. Stock options are fully vested.
- F4. Stock options vest in five equal annual installments commencing on May 26, 2027.
Key Figures
Merger share exchange ratio: 2.671 shares of common stock of Issuer
Direct common shares held: 66726 shares
Indirect common shares via IRA: 18630 shares
+2 more
5 metrics
Merger share exchange ratio
2.671 shares of common stock of Issuer
Each Signature common share converted into 2.671 Esquire common shares under the merger agreement.
Direct common shares held
66726 shares
Direct Esquire common stock holdings reported after merger-related acquisition on 2026-08-01.
Indirect common shares via IRA
18630 shares
Indirect Esquire common stock held through an IRA after merger conversion on 2026-08-01.
Stock option block at lowest exercise price
5953 options at $19.5700
Converted option exercisable for 5953 shares at $19.5700 per share, expiring 2026-10-01.
Highest option exercise price
$111.1400 per share
Option for 1861 shares at $111.1400 per share, expiring 2036-05-26, vesting over five annual installments.
Key Terms
Agreement and Plan of Merger, stock options, cash in lieu of fractional shares, fully vested
4 terms
Agreement and Plan of Merger regulatory
"Pursuant to the Agreement and Plan of Merger dated March 11, 2026 between the Issuer"
An Agreement and Plan of Merger is a formal document where two companies agree to combine into one, outlining how the process will happen. It’s like a step-by-step plan for merging, and it matters because it shows both sides have agreed on the details before the official transition takes place.
stock options financial
"This option converted into a stock option exercisable for a number of shares of Issuer"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
fully vested financial
"Stock options are fully vested."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Esquire Financial (ESQ) report for Michael G. O'Rourke?
Michael G. O'Rourke reported acquisitions of Esquire Financial common stock and stock options on 2026-08-01. These reflect conversions of his Signature Bancorporation equity into Esquire equity under the merger exchange ratio, not open-market purchases or sales.
How were Signature stock options treated in the Esquire Financial (ESQ) merger?
Each Signature stock option converted into an Esquire option for a number of shares equal to the original underlying shares multiplied by 2.671. The exercise price per share was divided by 2.671, rounded up to the nearest cent, preserving the option’s overall economic value.
Are O'Rourke’s Esquire Financial (ESQ) stock options vested?
Most reported stock options are described as fully vested. One stock option grant for 1861 shares at an exercise price of $111.1400 per share vests in five equal annual installments commencing on May 26, 2027.
Were the ESQ insider transactions made under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is not marked as being pursuant to such a plan. The transactions are reported as merger-related equity conversions and awards rather than trades executed under a pre-arranged Rule 10b5-1 plan.